BRAIDWELL LP - Q2 2024 holdings

$3.19 Billion is the total value of BRAIDWELL LP's 75 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 55.7% .

 Value Shares↓ Weighting
 GUARDANT HEALTH INCnote11/1$208,115,833
+13.4%
268,252,0000.0%6.53%
+10.3%
BuyBRIDGEBIO PHARMA INCnote 2.500% 3/1$142,965,899
-2.2%
140,838,000
+3.7%
4.48%
-4.8%
BuyNOVOCURE LTDnote11/0$129,792,037
+4.1%
140,834,000
+3.7%
4.07%
+1.4%
 NUVASIVE INCnote 0.375% 3/1$110,066,033
+0.9%
114,206,0000.0%3.45%
-1.7%
BuyCG ONCOLOGY INC$104,481,136
+110.6%
3,309,507
+192.8%
3.28%
+105.0%
NBIX BuyNEUROCRINE BIOSCIENCES INC$104,492,769
+3.8%
759,009
+3.9%
3.28%
+1.0%
XENE BuyXENON PHARMACEUTICALS INC$99,836,741
+77.3%
2,560,573
+95.8%
3.13%
+72.6%
BuyAPOGEE THERAPEUTICS INC$94,126,853
-23.1%
2,392,042
+29.8%
2.95%
-25.2%
BuyNEOGENOMICS INCnote 0.250% 1/1$90,849,918
+10.0%
116,381,000
+12.4%
2.85%
+7.1%
BuyIRONWOOD PHARMACEUTICALS INCnote 1.500% 6/1$84,647,255
+57.6%
89,740,000
+70.2%
2.66%
+53.4%
NewDEXCOM INCnote 0.375% 5/1$81,211,40082,700,000
+100.0%
2.55%
GH BuyGUARDANT HEALTH INC$81,094,116
+58.7%
2,807,968
+13.4%
2.54%
+54.5%
BuyINSULET CORPnote 0.375% 9/0$74,409,000
+8.1%
68,000,000
+3.0%
2.33%
+5.2%
LEGN BuyLEGEND BIOTECH CORPsponsored ads$73,951,899
+6.0%
1,669,720
+34.2%
2.32%
+3.2%
BuyDEXCOM INCnote 0.250%11/1$73,775,625
+3.1%
73,500,000
+13.1%
2.31%
+0.3%
ARGX SellARGENX SEsponsored adr$71,783,997
-17.1%
166,924
-24.1%
2.25%
-19.3%
ALGN BuyALIGN TECHNOLOGY INC$66,443,226
+19.7%
275,207
+62.6%
2.08%
+16.5%
MRVI BuyMARAVAI LIFESCIENCES HLDGS I$64,612,105
+3.2%
9,024,037
+25.0%
2.03%
+0.4%
PCVX SellVAXCYTE INC$61,034,960
-26.3%
808,303
-33.3%
1.92%
-28.3%
BuySPYRE THERAPEUTICS INC$59,116,788
+202.6%
2,514,538
+388.3%
1.85%
+194.3%
GKOS BuyGLAUKOS CORP$58,769,770
+38.3%
496,576
+10.2%
1.84%
+34.6%
VKTX BuyVIKING THERAPEUTICS INC$58,677,034
+0.3%
1,106,905
+55.2%
1.84%
-2.3%
IRTC BuyIRHYTHM TECHNOLOGIES INC$56,657,067
+1.1%
526,357
+8.9%
1.78%
-1.7%
BuyALPHATEC HLDGS INCnote 0.750% 8/0$56,550,744
+67.0%
58,217,000
+79.5%
1.77%
+62.6%
SellSAREPTA THERAPEUTICS INCnote 1.250% 9/1$55,512,074
-6.4%
43,066,000
-15.0%
1.74%
-8.9%
SellBRIDGEBIO PHARMA INCnote 2.250% 2/0$52,268,761
-5.2%
65,594,000
-2.5%
1.64%
-7.7%
INSP BuyINSPIRE MED SYS INC$50,780,857
+132.9%
379,443
+273.9%
1.59%
+126.6%
 TRAVERE THERAPEUTICS INCnote 2.500% 9/1$48,825,020
-1.7%
56,031,0000.0%1.53%
-4.2%
EXAS NewEXACT SCIENCES CORP$48,235,8961,141,678
+100.0%
1.51%
KROS BuyKEROS THERAPEUTICS INC$44,886,951
-8.0%
982,209
+33.2%
1.41%
-10.5%
ISRG  INTUITIVE SURGICAL INC$44,707,425
+11.5%
100,5000.0%1.40%
+8.4%
DAWN BuyDAY ONE BIOPHARMACEUTICALS I$41,834,757
+16.5%
3,035,904
+39.7%
1.31%
+13.4%
RGEN BuyREPLIGEN CORP$40,781,545
+55.2%
323,509
+126.5%
1.28%
+51.0%
NewAVADEL PHARMACEUTICALS PLC$40,754,8642,898,639
+100.0%
1.28%
TMO BuyTHERMO FISHER SCIENTIFIC INC$38,958,297
+42.2%
70,449
+49.4%
1.22%
+38.4%
NewKINIKSA PHARMACEUTICALS INTL$38,428,5172,058,303
+100.0%
1.20%
PEN SellPENUMBRA INC$38,260,542
-42.1%
212,594
-28.2%
1.20%
-43.6%
KIDS  ORTHOPEDIATRICS CORP$31,859,465
-1.4%
1,107,7700.0%1.00%
-4.0%
IRWD BuyIRONWOOD PHARMACEUTICALS INC$28,937,273
-4.8%
4,438,232
+27.2%
0.91%
-7.3%
TMDX SellTRANSMEDICS GROUP INC$28,611,775
-37.0%
189,960
-69.1%
0.90%
-38.7%
BuyPARAGON 28 INC$28,386,746
-31.7%
4,150,109
+23.3%
0.89%
-33.6%
IMCR NewIMMUNOCORE HLDGS PLCads$27,019,413797,268
+100.0%
0.85%
AKRO NewAKERO THERAPEUTICS INC$25,440,0241,084,400
+100.0%
0.80%
APLS NewAPELLIS PHARMACEUTICALS INC$23,468,648611,800
+100.0%
0.74%
ATEC NewALPHATEC HLDGS INC$22,936,7052,194,900
+100.0%
0.72%
BuyLEXEO THERAPEUTICS INC$22,174,995
+7.0%
1,382,481
+4.6%
0.70%
+4.2%
KRYS SellKRYSTAL BIOTECH INC$19,682,352
-37.5%
107,179
-39.5%
0.62%
-39.3%
RLAY SellRELAY THERAPEUTICS INC$19,604,329
-36.9%
3,006,799
-19.7%
0.62%
-38.6%
NVRO SellNEVRO CORP$14,303,627
-44.2%
1,698,768
-4.4%
0.45%
-45.7%
LXRX NewLEXICON PHARMACEUTICALS INC$13,935,5168,294,950
+100.0%
0.44%
ARVN NewARVINAS INC$13,768,663517,230
+100.0%
0.43%
SRPT NewSAREPTA THERAPEUTICS INC$12,940,20081,900
+100.0%
0.41%
IOVA BuyIOVANCE BIOTHERAPEUTICS INC$11,762,212
+20.2%
1,466,610
+122.2%
0.37%
+17.1%
OCUL NewOCULAR THERAPEUTIX INC$11,243,3871,643,770
+100.0%
0.35%
ALEC  ALECTOR INC$10,808,396
-24.6%
2,380,7040.0%0.34%
-26.6%
SellHAEMONETICS CORP MASSnote3/0$10,367,250
-47.8%
11,500,000
-46.5%
0.32%
-49.2%
SKIN NewTHE BEAUTY HEALTH COMPANY$9,831,7155,120,685
+100.0%
0.31%
LIVN NewLIVANOVA PLC$9,533,198173,900
+100.0%
0.30%
NewDIANTHUS THERAPEUTICS INC$9,494,104366,851
+100.0%
0.30%
REPL NewREPLIMUNE GROUP INC$9,120,3931,013,377
+100.0%
0.29%
CSTL NewCASTLE BIOSCIENCES INC$9,058,497416,100
+100.0%
0.28%
BBIO BuyBRIDGEBIO PHARMA INC$8,753,313
-17.9%
345,571
+0.2%
0.28%
-20.1%
CELC NewCELCUITY INC$8,462,612516,643
+100.0%
0.26%
FDMT Sell4D MOLECULAR THERAPEUTICS IN$7,754,923
-76.9%
369,458
-64.9%
0.24%
-77.5%
ELEV BuyELEVATION ONCOLOGY INC$6,689,558
-45.2%
2,477,614
+4.2%
0.21%
-46.6%
HROW BuyHARROW INC$6,208,257
+272.5%
297,188
+135.9%
0.20%
+261.1%
LBPH NewLONGBOARD PHARMACEUTICALS IN$5,566,180205,926
+100.0%
0.18%
 CUTERA INCnote 4.000% 6/0$5,031,513
-21.8%
29,000,0000.0%0.16%
-23.7%
 CUTERA INCnote 2.250% 6/0$5,048,000
-12.1%
25,240,0000.0%0.16%
-14.6%
LUNG  PULMONX CORP$4,771,110
-31.6%
752,5410.0%0.15%
-33.3%
NewCONMED CORPnote 2.250% 6/1$4,477,5675,000,000
+100.0%
0.14%
CGEM SellCULLINAN THERAPEUTICS INC$3,072,457
-85.5%
176,173
-85.8%
0.10%
-85.9%
OM SellOUTSET MED INC$2,673,921
-49.8%
694,525
-71.1%
0.08%
-51.2%
NewDBV TECHNOLOGIES S Asponsored adr$1,956,4462,442,504
+100.0%
0.06%
ETNB New89BIO INC$1,315,458164,227
+100.0%
0.04%
ADPT ExitADAPTIVE BIOTECHNOLOGIES COR$0-1,357,490
-100.0%
-0.14%
DBVT ExitDBV TECHNOLOGIES S Asponsored adr$0-7,843,285
-100.0%
-0.19%
OLMA ExitOLEMA PHARMACEUTICALS INC$0-704,344
-100.0%
-0.26%
DCPH ExitDECIPHERA PHARMACEUTICALS IN$0-609,643
-100.0%
-0.31%
ARQT ExitARCUTIS BIOTHERAPEUTICS INC$0-1,300,000
-100.0%
-0.42%
ExitMINERALYS THERAPEUTICS INC$0-1,147,154
-100.0%
-0.48%
ITOS ExitITEOS THERAPEUTICS INC$0-1,162,374
-100.0%
-0.51%
BCRX ExitBIOCRYST PHARMACEUTICALS INC$0-3,379,577
-100.0%
-0.55%
ExitSTRUCTURE THERAPEUTICS INCsponsored ads$0-435,823
-100.0%
-0.60%
BMRN ExitBIOMARIN PHARMACEUTICAL INC$0-218,896
-100.0%
-0.62%
ExitIRONWOOD PHARMACEUTICALS INCnote 0.750% 6/1$0-20,000,000
-100.0%
-0.64%
ExitTOURMALINE BIO INC$0-906,820
-100.0%
-0.67%
KNSA ExitKINIKSA PHARMACEUTICALS LTD$0-1,392,716
-100.0%
-0.89%
ExitKARYOPHARM THERAPEUTICS INCnote 3.000%10/1$0-65,976,000
-100.0%
-1.15%
AVDL ExitAVADEL PHARMACEUTICALS PLCsponsored adr$0-2,668,549
-100.0%
-1.45%
ExitINSMED INCnote 1.750% 1/1$0-64,887,000
-100.0%
-2.24%
ExitEXACT SCIENCES CORPnote 0.375% 3/0$0-144,000,000
-100.0%
-4.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
GUARDANT HEALTH INC7Q2 20246.9%
NOVOCURE LTD7Q2 20244.3%
BRIDGEBIO PHARMA INC7Q2 20245.1%
XENON PHARMACEUTICALS INC7Q2 20243.1%
VAXCYTE INC7Q2 20243.0%
NUVASIVE INC7Q2 20243.5%
ALPHATEC HLDGS INC7Q2 20243.6%
GLAUKOS CORP7Q2 20243.0%
ALIGN TECHNOLOGY INC7Q2 20242.6%
IRHYTHM TECHNOLOGIES INC7Q2 20242.2%

View BRAIDWELL LP's complete holdings history.

Latest filings
TypeFiled
N-PX2024-08-30
13F-HR2024-08-14
13F-HR2024-05-15
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15

View BRAIDWELL LP's complete filings history.

Export BRAIDWELL LP's holdings